SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-013035
Filing Date
2017-03-01
Accepted
2017-03-01 16:03:26
Documents
3
Period of Report
2017-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-7420_18k.htm 8-K 24348
2 EX-99.1 a17-7420_1ex99d1.htm EX-99.1 9741
3 GRAPHIC g74201mmi001.jpg GRAPHIC 4825
  Complete submission text file 0001104659-17-013035.txt   42365
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 17654053
SIC: 2835 In Vitro & In Vivo Diagnostic Substances